Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2023
Direct co-registration of [<sup>18</sup>F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility studyJens M Debacker, Luna Maris, Fleur Cordier, et al.
European Urology Focus|August 11, 2018
Robot-assisted Kidney Autotransplantation: A Minimally Invasive Way to Salvage KidneysKarel Decaestecker, Benjamin Van Parys, Jeroen Van Besien, et al.
JAMA Surgery|June 17, 2026
Specimen PET-CT Imaging for Intraoperative Margin Assessment in Early-Stage Breast Cancer: The BrIMA Nonrandomized Clinical TrialMenekse Göker, Markus Hahn, Ximena Elzo Kraemer, et al.
European Urology Focus|February 19, 2025
Adjuvant Radiotherapy After Radical Cystectomy for Muscle-invasive Bladder Cancer: A Phase 2 Trial-Results of Secondary EndpointsFlor Verghote, Elke Rammant, Piet Dirix, et al.
Urologia Internationalis|February 2, 2026
Pelvic lymph node dissection during radical prostatectomy for prostate cancer: harms versus benefitsEva Donck, Claudia Fede Spicchiale, Tong Yang, et al.
Diagnostics (Basel, Switzerland)|October 18, 2017
Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer PatientsWouter Huysse, Frédéric Lecouvet, Paolo Castellucci, et al.
BMC Cancer|October 19, 2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trialFlor Verghote, Lindsay Poppe, Sofie Verbeke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialPiet Ost, Dries Reynders, Karel Decaestecker, et al.
BJU International|June 25, 2017
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapyAurélie De Bruycker, Bieke Lambert, Tom Claeys, et al.
Gynecologic Oncology|August 30, 2020
Splenic <sup>18</sup>F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancerEmiel A De Jaeghere, Frederiek Laloo, Lien Lippens, et al.
Pageof 4